Multiple sclerosis drugs on every 2026 Virgin Islands Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 1 stand-alone Part D plans in Virgin Islands cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | AARP Medicare Rx Preferred from UHC$114.80/moS5820-038 |
|---|---|
| Kesimptaofatumumab | Not covered |
| teriflunomidegeneric Aubagio | Tier 425%QL 30/30d |
| dimethyl fumarategeneric Tecfidera | Tier 425%QL 56/28d |
| Vumeritydiroximel fumarate | Not covered |
| fingolimodgeneric Gilenya | Tier 425%QL 30/30d |
| Mayzentsiponimod | Not covered |
| Zeposiaozanimod | Not covered |
| Mavencladcladribine | Not covered |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.